Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Event driven strategies outperform over the first half of 2014

Friday, July 11, 2014

Bailey McCann, Opalesque New York:

Event driven strategies, driven by the success of activists outperformed within the hedge fund cohort for the month of June, Q2, and the first half of 2014 according to the latest hedge fund performance data from eVestment. Overall hedge fund performance was also positive for June, marking the second consecutive month. The industry returned 1.14% in June, 1.89% in Q2 and ended the first half up 3.08%, on pace for an annualized return of 6.26% for the year, lagging 2013 and 2012.

Activist hedge funds posted large gains in June, an average of 3.51%, making the group the best performing strategy in both Q2 and H1 2014. Event driven funds are on pace to return over 12% for a second straight year. Distressed funds followed close behind posting returns of 1.07% for June.

Long/short equity strategies posted positive returns in June, Q2 and H1, but are generally lagging other major segments of the industry in 2014. Credit funds posted their tenth consecutive positive month in June, returning 0.69%, and are the second best performing primary market-focus behind volatility strategies. The continued decline in longer-term UST yields continues to be a positive for the universe, which is on pace to outperform 2013 gains.

Macro strategies were positive for the second consecutive month, but H1 returns put them at the bottom of the industry in terms of major strategies, below managed futures funds.

......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its